NUREMBERG, Germany, March 10, 2026, 15:14 CET
Intel introduced a new slate of processors targeting industrial and medical sectors at Embedded World in Nuremberg on Tuesday, stepping up its edge AI push with CEO Lip-Bu Tan at the helm as he attempts to steer the U.S. chipmaker back on course. The company said systems with the new chips are already shipping. A healthcare software suite tied to the launch is set for wider distribution in the second quarter.
It’s a significant moment for Intel, which faces mounting scrutiny over whether it can meet chip delivery timelines and capture AI-driven growth outside Nvidia’s stronghold in expensive data-center products. This update arrives only two months after Intel unveiled Panther Lake—its first PC chip built with the 18A process, marking a major move forward for the company.
Just days after CFO David Zinsner disclosed that Tan is still deciding whether to keep 18A mostly internal or open it up to external foundry customers as yields improve, Intel last week announced board chair Frank Yeary will step down in May. Longtime chip industry veteran Craig Barratt is set to take his place. Tan’s shakeup now reaches from the shop floor all the way to the board level.
Intel’s Core Series 2 chips are being aimed squarely at mission-critical edge environments—places where reliability trumps outright performance. The company says factory floors and medical tech can lean on these new processors to run control tasks and AI in parallel, staying on schedule without hiccups or lag.
Dan Rodriguez, head of Intel’s edge computing division, described edge as “one of our fastest-growing business segments.” Rodriguez said Intel is looking to broaden both hardware and software options for clients who want to run AI close to where their data is generated, instead of sending all the data to faraway cloud infrastructure. Newsroom
Intel took the wraps off its Edge AI Suite for Health & Life Sciences, introducing reference kits for ECG arrhythmia detection, pulse tracking from video, and privacy-minded 3D motion study. The company said a preview build is up now on GitHub, with broader rollout planned for the second quarter.
Intel didn’t miss a beat going after AMD, saying its latest chips outstrip AMD’s Ryzen 7 9700X in several latency and response-time tests. The jab comes as Intel has been ceding PC market share to AMD, while Taiwan Semiconductor Manufacturing Co. continues to pick up steam on the manufacturing side.
Intel jumped about 1.6% in early U.S. trading Tuesday. The stock’s been swinging as traders size up Tan’s push for deep cost cuts and a slate of next-gen products, set against a turnaround story that still has plenty of skeptics. January saw Gabelli Funds analyst Ryuta Makino call Intel sentiment the best he’d seen in years.
The fresh edge release doesn’t fix Intel’s bigger execution woes. Back in January, the company admitted it was struggling to meet server CPU demand when those chips get paired with AI hardware. Tan said 18A yields are improving, though still falling short of his expectations. “Supply-constrained rather than demand-constrained,” is how Michael Schulman of Running Point Capital put Intel’s turnaround. And last week, U.S. lawmakers raised national security concerns about Intel’s tests of ACM Research tools with Chinese ties. Intel’s answer: those tools aren’t used on its production lines, and the company says it’s complying with U.S. law. Reuters
